IL-22及其受体在人类和实验性COPD中升高并参与发病机制
该研究探讨IL-22在人类COPD及香烟烟雾诱导的实验性COPD中的作用。结果显示COPD患者和实验性COPD小鼠肺内IL-22及IL-22受体表达均升高,IL-22缺失小鼠香烟烟雾诱导的中性粒细胞浸润、气道重塑和肺气肿样改变减轻且肺功能改善。
要点
- COPD患者IL-22及IL-22受体mRNA和蛋白水平较健康吸烟或非吸烟对照升高
- 实验性COPD小鼠肺内IL-22及受体升高,细胞来源包括CD4+T细胞、γδT细胞、NKT细胞和3型固有淋巴细胞
- IL-22缺失小鼠香烟烟雾诱导的中性粒细胞浸润、气道重塑和肺气肿样肺泡扩大减轻,肺功能改善
核心结论
- IL-22及其受体在人类COPD和香烟烟雾诱导的实验性COPD中升高,并参与COPD发病机制。
研究设计与样本
- 研究比较了COPD患者与健康吸烟或非吸烟对照的IL-22及IL-22受体表达,并采用香烟烟雾诱导的实验性COPD小鼠模型及IL-22缺陷(Il22-/-)小鼠进行机制研究。
主要发现
- COPD患者IL-22和IL-22受体mRNA表达及蛋白水平较健康吸烟或非吸烟对照升高。
- 实验性COPD小鼠肺内IL-22及IL-22受体水平较对照升高,IL-22细胞来源包括CD4+T辅助细胞、γδT细胞、自然杀伤T细胞和3型固有淋巴细胞。
- 香烟烟雾诱导的肺中性粒细胞在IL-22缺陷小鼠中减少。
- 香烟烟雾诱导的气道重塑和肺气肿样肺泡扩大未在Il22-/-小鼠中发生。
- Il22-/-小鼠在气道阻力、总肺容量、吸气容量、用力肺活量和顺应性方面肺功能改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and death globally. The lack of effective treatments results from an incomplete understanding of the underlying mechanisms driving COPD pathogenesis.Interleukin (IL)-22 has been implicated in airway inflammation and is increased in COPD patients. However, its roles in the pathogenesis of COPD is poorly understood. Here, we investigated the role of IL-22 in human COPD and in cigarette smoke (CS)-induced experimental COPD.IL-22 and IL-22 receptor mRNA expression and protein levels were increased in COPD patients compared to healthy smoking or non-smoking controls. IL-22 and IL-22 receptor levels were increased in the lungs of mice with experimental COPD compared to controls and the cellular source of IL-22 included CD4+ T-helper cells, γδ T-cells, natural killer T-cells and group 3 innate lymphoid cells. CS-induced pulmonary neutrophils were reduced in IL-22-deficient (Il22 -/-) mice. CS-induced airway remodelling and emphysema-like alveolar enlargement did not occur in Il22 -/- mice. Il22 -/- mice had improved lung function in terms of airway resistance, total lung capacity, inspiratory capacity, forced vital capacity and compliance.These data highlight important roles for IL-22 and its receptors in human COPD and CS-induced experimental COPD.
引用
- Starkey MR, Plank MW, Casolari P, et al. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J. 2019. PMID: 31196943. doi:10.1183/13993003.00174-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。